Skip to Content

Notice

Achieving a Future Vision at the 2008 Parenteral Drug Association and the Food and Drug Administration Joint Regulatory Conference

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice of meeting.

The Food and Drug Administration (FDA) is announcing the following meeting: Achieving a Future Vision at the 2008 Parenteral Drug Association and the Food and Drug Administration Joint Regulatory Conference. The topics to be discussed are: FDA's Pharmaceutical Inspectorate and the Global Harmonization Task Force; Trans Atlantic initiative; Product development; and legacy products; Supply chain; Combination products; and Recall root causes.

Date and Time: The meeting will be held on September 8 through 12, 2008, 7 a.m. to 6.

Location: The meeting will be held at Renaissance Hotel, 999 9th St., NW., Washington, DC 20001.

Contact: Wanda Neal-Ballard, Parenteral Drug Association, PDA Global Headquarters, Bethesda Towers, 4350 East West Hwy., Suite 200, Bethesda, MD 20814 or by telephone on 301-986-0293, ext. 111.

Registration and Meeting Information: See PDA Web site, www.pda.org/​pdafda2008 or contact Wanda Neal-Ballard on 301-986-0293, ext. 111. From now until August 25, 2008, registration fees are as follows: $1,600.00 for Members, $2,000.00 for Non-members, $615.00 for Government/Health Authority/Academic and $230.00 for Students. After August 25, 2008, registration fees are as follows: $1,800.00 for Members, $2,200.00 for Non-members, $700.00 for Government/Health Authority/Academic and $260.00 for Students.

If you need special accommodations due to a disability, please contact Wanda Neal-Ballard at least 7 days in advance.

Start Signature

Dated: August 18, 2008.

Jeffrey Shuren,

Associate Commissioner for Policy and Planning.

End Signature End Preamble

[FR Doc. E8-19491 Filed 8-21-08; 8:45 am]

BILLING CODE 4160-01-S